For instance, metabolomic analyses revealed that NPM1-mutated AML is characterized by high levels of free carnitine, whereas FLT3-ITD displays significant alterations in amino acid metabolism, particularly involving glutamic and aspartic acids, highlighting the key role of glutaminolysis and energy metabolism pathways in differentiating these subtypes [162]. The gene discussed is NPM1; the disease is acute myeloid leukemia.